EMAIL THIS PAGE TO A FRIEND

British Journal of Pharmacology

Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells.


PMID 15723090

Abstract

We're sorry this abstract is currently not available.